CymitQuimica logo

CAS 943319-70-8

:

Ponatinib

Description:
Ponatinib is a targeted therapy medication primarily used in the treatment of certain types of leukemia, particularly chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL) that are resistant to other treatments. It is classified as a tyrosine kinase inhibitor, specifically designed to inhibit the BCR-ABL fusion protein, which is often responsible for the proliferation of cancer cells in these conditions. The chemical formula of ponatinib reflects its complex structure, which includes multiple functional groups that contribute to its pharmacological activity. It is characterized by its ability to cross the blood-brain barrier, making it effective for central nervous system involvement in leukemia. Ponatinib is administered orally and is known for its potential side effects, which can include cardiovascular issues, hypertension, and myelosuppression. Due to its potency and the risk of serious adverse effects, its use is typically reserved for patients who have not responded to other therapies. Monitoring and management of side effects are crucial during treatment with ponatinib.
Formula:C29H27F3N6O
InChI:InChI=1S/C29H27F3N6O/c1-20-5-6-22(16-21(20)8-10-25-18-33-27-4-3-11-34-38(25)27)28(39)35-24-9-7-23(26(17-24)29(30,31)32)19-37-14-12-36(2)13-15-37/h3-7,9,11,16-18H,12-15,19H2,1-2H3,(H,35,39)
InChI key:InChIKey=PHXJVRSECIGDHY-UHFFFAOYSA-N
SMILES:C(#CC1=CC(C(NC2=CC(C(F)(F)F)=C(CN3CCN(C)CC3)C=C2)=O)=CC=C1C)C=4N5C(=NC4)C=CC=N5
Synonyms:
  • 3-(2-Imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-[4-[(4-methyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl]benzamide
  • Ap 24534
  • Ap24534
  • Benzamide, 3-(2-imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-[4-[(4-methyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl]-
  • Iclusig
  • Ponatinib
  • AP24534(Ponatinib)
  • 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)benzamide
  • Ponatinib hybrochloride
  • AP24534 hybrochloride
  • See more synonyms
Sort by

Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 8 products.
  • Ponatinib, Free Base

    CAS:
    <p>Ponatinib, Free Base</p>
    Formula:C29H27F3N6O
    Purity:98%
    Color and Shape: solid
    Molecular weight:532.56g/mol

    Ref: 54-BIM1122

    10mg
    37.00€
    100mg
    137.00€
    250mg
    228.00€
  • Ponatinib

    CAS:
    Ponatinib
    Purity:≥98%
    Molecular weight:532.56g/mol

    Ref: 54-BUP14504

    5mg
    55.00€
    10mg
    73.00€
    25mg
    83.00€
    50mg
    94.00€
    100mg
    139.00€
    500mg
    295.00€
  • Ponatinib

    CAS:
    Formula:C29H27F3N6O
    Color and Shape:Pale Yellow Solid
    Molecular weight:532.57

    Ref: 4Z-P-123001

    5mg
    To inquire
    10mg
    349.00€
    25mg
    444.00€
    50mg
    635.00€
    100mg
    To inquire
  • Ponatinib

    CAS:
    <p>Ponatinib (AP24534) is an orally available, multitargeted kinase inhibitor (IC50s: 0.37/1.1/1.5/2.2/5.4 nM for Abl, PDGFRα, VEGFR2, FGFR1, and Src, respectively</p>
    Formula:C29H27F3N6O
    Purity:98% - 99.60%
    Color and Shape:Solid
    Molecular weight:532.56
  • Ponatinib

    CAS:
    Formula:C29H27F3N6O
    Purity:≥ 98.0%
    Color and Shape:White or off-white powder or crystals
    Molecular weight:532.56

    Ref: 7W-GP1345

    10mg
    74.00€
  • Ponatinib

    Controlled Product
    CAS:
    <p>Applications Ponatinib is a tyrosine kinase inhibitors (TKI) and used to treat chronic myeloid leukemia (CML) (1,2,3). Ponatinib is also used in combination with other drugs, such as forskolin, to combat TKI resistance in patient with CML (3), targeted drug in small-cell lung cancer. Potent FAK inhibitor. FGFR/VEGFR/Bcr-Abl inhibitor It is a COVID19-related research product.<br>References (1) Poch, M. M., et al.: Expert Rev Hematol. 9, 923 (2016) (2) Shamroe, C. L. and Comeau, J. M. Ann Pharmacother. 47, 1540 (2013)(3) Oaxaca, D. M., et al.: Tumour Biol. 37, 12643 (2016)<br></p>
    Formula:C29H27F3N6O
    Color and Shape:Off-White
    Molecular weight:532.56

    Ref: TR-P688250

    1mg
    89.00€
    10mg
    151.00€
    25mg
    273.00€
  • Ponatinib

    CAS:
    <p>BCR-ABL1 tyrosine kinase inhibitor</p>
    Formula:C29H27F3N6O
    Purity:Min. 95%
    Color and Shape:Powder
    Molecular weight:532.56 g/mol

    Ref: 3D-FP27104

    50mg
    183.00€
    100mg
    349.00€
    250mg
    487.00€
  • Ponatinib Glucuronide

    Controlled Product
    CAS:
    Formula:C35H35F3N6O7
    Color and Shape:Neat
    Molecular weight:709.692

    Ref: TR-P688255

    50mg
    8,364.00€